Skip to main content
. 2024 Feb 27;16(2):211–228. doi: 10.4254/wjh.v16.i2.211

Figure 3.

Figure 3

The cumulative incidence of study outcomes in the acute phase vs post-acute phase of infection. A: Hepatocellular carcinoma; B: All-cause mortality; C: Adverse hepatic outcomes; D: Palliative care. HCC: Hepatocellular carcinoma; COVID-19: Coronavirus disease 2019.